David C•••

About

On the record

I’m a molecular biologist and epigenetics researcher with 25+ years of experience bridging academia, clinical trials, and biotech innovation. I’m fascinated by how epigenetic changes drive disease—and how we can translate that science into real diagnostics. Over my career, I’ve led projects from lab bench to clinical trial (NCT03483922), navigating FDA registration, CAP/CLIA accreditation, and HIPAA compliance. I've co-invented 3 patents in cancer detection and epigenetic age testing, and published more than 30 peer-reviewed papers on DNA methylation, biomarkers, and cancer diagnostics. Today, I split my time between leadership and consulting: Chief Innovation Officer at epiMedTech Global (Singapore), Chief Scientific Officer and Co-Founder of NanoWellness Inc (Canada), Founder of Biotech Insight Solutions, and Affiliate Member of the Gerald Bronfman Department of Oncology at McGill University. I’m fluent in English, Hebrew, Russian, and Georgian, with intermediate French. I value collaboration across cultures and disciplines, and enjoy helping biotech teams deliver innovative, clinically validated products.